PLCB1 and central nervous system cancer: Indeed, a previous in silico study reported that PLCβ1, one of the most represented PLCs in the brain, is a potential prognostic factor and accordingly, a candidate signature gene for specific subtypes of glioblastoma and that PLCβ1 expression was inversely correlated with glioma pathological grades [26].